7 Stocks 'On Sale' This Holiday Season

7 Stocks 'On Sale' This Holiday Season

The SPDR S&P 500 ETF Trust SPY has generated a total return of 26.4% year-to-date, but much of those overall gains have been driven by a handful of megacap stocks. In fact, 65 stocks in the S&P 500 are currently in the red year-to-date in 2021.

When a stock struggles in a bull market, it’s often an indication that there’s something fundamentally wrong with the underlying company’s business. However, sometimes market technicals, cyclicality, investor sentiment or even a healthy valuation reset can trigger temporary underperformance in high-quality stocks.

Related Link: BEST STOCKS UNDER $20

This time of year, it may feel like you’ve missed out on big rallies in the best stocks. But, there may still be a chance to buy some high-quality stocks for 2022 at a discount to what you would have paid a year ago.

But there’s a big difference between buying the dip in a quality stock and trying to catch a falling knife.

Benzinga screened for S&P 500 stocks that have consensus Buy ratings among Wall Street analysts, forward PE ratios of under 15 and year-to-date losses of at least 15%. Here are the seven stocks on sale that met those three criteria:

  • Global Payments Inc GPN, year-to-date loss of 41.9%.
  • Viatris Inc VTRS, year-to-date loss of 29.7%.
  • Incyte Corporation INCY, year-to-date loss of 26.6%.
  • Fidelity National Information Servcs Inc FIS, year-to-date loss of 23.1%.
  • Vertex Pharmaceuticals Incorporated VRTX, year-to-date loss of 20.9%.
  • FleetCor Technologies, Inc. FLT, year-to-date loss of 17.1%.
  • Fiserv Inc FISV, year-to-date loss of 15.5%.

Image by Press 👍👍 Love you 💖 from Pixabay 

Posted In: pharmaceuticalsFintechLong IdeasNewsHealth CareTop StoriesTechTrading IdeasGeneral
Fintech Focus Newsletter

Your update on what’s going on in the Fintech space. Keep up-to-date with news, valuations, mergers, funding, and events. Sign up today!